BioMarin Pharmaceutical | BMRN - 销售毛利

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.28B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	销售毛利	更改		日
Acadia Pharmaceuticals	USD 257.76M		778K	2025-12
Agios Pharmaceuticals	USD 18.09M		6.89M	2025-12
Alnylam Pharmaceuticals	USD 829.31M		219.56M	2025-12
Amgen	USD 6.48B		307M	2025-09
Bayer	EUR 5.35B		1.02B	2025-09
Biogen	USD 1.65B		34.6M	2025-12
BioMarin Pharmaceutical	USD 713.01M		81.81M	2025-12
Gilead Sciences	USD 6.31B		106M	2025-12
Incyte	USD 1.17B		217.51M	2026-03
Insmed	USD 217.69M		106.25M	2025-12
Ionis Pharmaceuticals	USD 195M		40M	2025-12
Moderna	USD 226M		583M	2025-12
Neurocrine Biosciences	USD 787.9M		7M	2025-12
PTC Therapeutics	USD 148.38M		39.31M	2025-12
Puma Biotechnology	USD 20.32M		24.85M	2024-09
Regeneron Pharmaceuticals	USD 3.3B		67M	2025-12
Roche Holding	CHF 22.09B		10.04B	2025-12
Sangamo BioSciences	-2.39M		1.09M	2024-06
Sanofi	EUR 8.45B		3.02B	2025-12
Sarepta Therapeutics	USD 43.55M		204.36M	2025-12
Ultragenyx Pharmaceutical	USD 178M		46.06M	2025-12
United Therapeutics	USD 315.5M		286.6M	2025-12
Vertex Pharmaceuticals	USD 2.72B		62.4M	2025-12